Fidelis Capital Partners’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$404K Sell
5,674
-4,644
-45% -$366K 0.03% 352
2025
Q4
$846K Buy
10,318
+1,042
+11% +$81.2K 0.06% 230
2025
Q3
$697K Buy
+9,276
New +$692K 0.05% 249
2025
Q1
Sell
-2,679
Closed -$234K 444
2024
Q4
$234K Buy
+2,679
New +$228K 0.02% 385

Other funds holding GEHC

Fidelis Capital Partners's GEHC Position: Q1 2026 in Review

Fidelis Capital Partners reduced its GE HealthCare (GEHC) stake by 45% in Q1 2026, selling an estimated $366K and leaving 5,674 shares worth $404K. The position accounts for 0.03% of the portfolio, ranked #352.

Fidelis Capital Partners first reported a position in GEHC in Q4 2024 and has held it in 4 quarters since. The position peaked at $846K in Q4 2025. 1,269 funds tracked by Wall St. Rank hold GEHC as of Q1 2026.

  • Fidelis Capital Partners held 5,674 shares of GE HealthCare worth $404K as of Q1 2026.
  • Fidelis Capital Partners sold 4,644 GE HealthCare shares in Q1 2026, an estimated $366K.
  • GE HealthCare made up 0.03% of Fidelis Capital Partners's portfolio in Q1 2026, its #352 holding.
  • Fidelis Capital Partners first reported a position in GE HealthCare in Q4 2024 and has held it in 4 quarters since.
  • Fidelis Capital Partners's GE HealthCare position peaked at $846K in Q4 2025.
  • 1,269 funds tracked by Wall St. Rank held GE HealthCare as of Q1 2026.

Based on Fidelis Capital Partners's 13F filing for Q1 2026, filed 6 May 2026.